Advanced in Atherosclerosis

Dr. Carl J. Pepine

Cardiology
Florida Clinical Practice Association Inc
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, 
Gainesville, FL 
Accepting New Patients
Advanced in Atherosclerosis
Florida Clinical Practice Association Inc
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Carl Pepine is a Cardiologist in Gainesville, Florida. Dr. Pepine is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Angina, Coronary Heart Disease, Hypertension, Bone Marrow Aspiration, and Percutaneous Coronary Intervention (PCI). Dr. Pepine is currently accepting new patients.

His clinical research consists of co-authoring 468 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 20 articles in the study of Atherosclerosis.

Specialties
Cardiology
Licenses
Internal Medicine in FL
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, Gainesville, FL 32608
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
4037 Nw 86th Ter, Fl 3, Gainesville, FL 32606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Drug, Behavioral
Study Drugs: Statin, Lisinopril, Losartan, Aspirin
Study Phase: Phase 4
Gut Inflammation and Gut-Gut Microbiome Interactions in the Pathogenesis of Hypertension
Gut Inflammation and Gut-Gut Microbiome Interactions in the Pathogenesis of Hypertension
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Other
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)
Enrollment Status: Completed
Publish Date: September 19, 2025
Intervention Type: Other, Biological
Study Drug: Autologous Cell Therapy
Study Phase: Phase 3
The Role of Gut Microbiota in Hypertension: Brain-Gut Microbiome-Immune Axis in Hypertension
The Role of Gut Microbiota in Hypertension: Brain-Gut Microbiome-Immune Axis in Hypertension
Enrollment Status: Completed
Publish Date: August 17, 2025
Intervention Type: Other
Characterize the Gut Microbiota in Subjects With Heart Failure and Pre-heart Failure With Preserved Ejection Fraction
Characterize the Gut Microbiota in Subjects With Heart Failure and Pre-heart Failure With Preserved Ejection Fraction
Enrollment Status: Withdrawn
Publish Date: April 10, 2025
Intervention Type: Other
Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Umbilical Cord Lining Stem Cells
Study Phase: Early Phase 1
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Enrollment Status: Completed
Publish Date: January 10, 2022
Intervention Type: Biological, Other
Study Phase: Phase 3
A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF
A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy
A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy
Enrollment Status: Completed
Publish Date: November 05, 2020
Intervention Type: Biological
Study Phase: Phase 1
View 9 Less Clinical Trials

468 Total Publications

The Gut Microbiome and Cardiac Arrhythmias.
The Gut Microbiome and Cardiac Arrhythmias.
Journal: Federal practitioner : for the health care professionals of the VA, DoD, and PHS
Published: October 06, 2025
Similar Doctors
Elite in Atherosclerosis
Dr. Jihad A. Mustapha
Cardiology | Interventional Cardiology
Elite in Atherosclerosis
Dr. Jihad A. Mustapha
Cardiology | Interventional Cardiology

Shreeven LLC

1609 Sw 17th St, 
Ocala, FL 
 (33.8 miles away)
352-401-9888
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jihad Mustapha is a Cardiologist and an Interventional Cardiologist in Ocala, Florida. Dr. Mustapha is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Varicose Veins, Atherectomy, and Angioplasty. Dr. Mustapha is currently accepting new patients.

Distinguished in Atherosclerosis
Dr. Bashar S. Saikaly
Cardiology
Distinguished in Atherosclerosis
Dr. Bashar S. Saikaly
Cardiology

Drs Baker And Gilmour MD PA

12276 San Jose Blvd, Suite 617, 
Jacksonville, FL 
 (55.1 miles away)
904-733-4444
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bashar Saikaly is a Cardiologist in Jacksonville, Florida. Dr. Saikaly is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, and Glucocorticoid-Remediable Aldosteronism. Dr. Saikaly is currently accepting new patients.

Distinguished in Atherosclerosis
Dr. Nishant K. Nerella
Cardiology
Distinguished in Atherosclerosis
Dr. Nishant K. Nerella
Cardiology

Citrus Cardiology Consultants, PLLC

308 W Highland Blvd, 
Inverness, FL 
 (55.3 miles away)
352-726-8353
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Nishant Nerella is a Cardiologist in Inverness, Florida. Dr. Nerella is rated as a Distinguished provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Necrosis, Angina, Mitral Valve Regurgitation, and Heart Attack. Dr. Nerella is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pepine's expertise for a condition
ConditionClose
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile